The complexity of Parkinson’s disease is accompanied by clinical challenges, including an inability to make a definitive diagnosis at the earliest stages of the disease and difficulties in the management of symptoms at later stages.

Current treatments options revolve around medication to restore dopamine levels in the brain, and while they may improve symptoms, they are not a cure for the disease.

The therapy at our clinic’s is aimed to slow down or stop the progression of Parkinson’s disease, which is a chronic, neurodegenerative, and idiopathic condition. We achieve this with the tissue regeneration properties of stem cells in conjunction with the growth factors and the anti-inflammatory biomolecules of exosomes.